在股东批准之后,Caladrius董事会批准了Caladrius普通股的反向股票拆分,比例为每15股发行在外的股票换1股新股。
合并后的公司将更名为...查看全文
牛股小红书2022-04-28 13:52
临床阶段生物技术公司$Caladrius生物科学(CLBS)$ 与私营企业Cend Therapeutics达成的合并协议。
根据协议条款,Cend将与Caladrius(CLBS)的一个子公司进行全股票交易合并,合并后的公司Lisata Therapeutics将在纳斯达克上市,股票代码为“LSTA”
因此,卡拉德里乌斯(CLBS)首席执行官戴...查看全文
Edward16992021-02-19 19:25
$Caladrius生物科学(CLBS)$ 两个产品一个在日本的phase 2,一个在美国的phase 2b。很大的upside potential。查看全文
Richardlim2021-01-21 02:07
$Tengasco(TGC)$ 起飞了?
向前辈学习 $Obalon Therapeutics(OBLN)$ $Caladrius生物科学(CLBS)$查看全文
$Caladrius Biosciences, Inc.(CLBS)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-03-17 AccNo: 0000320017-17-000015 Size: 125 KB 网页链接
$Caladrius Biosciences, Inc.(CLBS)$ 8-K - Current report Filed: 2017-03-17 AccNo: 0000320017-17-000014 Size: 126 KBItem 2.02: Results of Operations and Financial ConditionItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Caladrius Biosciences, Inc.(CLBS)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2017-03-17 AccNo: 0000320017-17-000008 Size: 8 MB 网页链接
$Caladrius Biosciences, Inc.(CLBS)$ 美东时间 2017-03-17 盘前 披露财报,预期EPS n/a 网页链接
$Caladrius Biosciences, Inc.(CLBS)$ 内部交易: 2017-02-06,Director,Wei Eric ,卖出,500普通股, $4.75
$Caladrius Biosciences, Inc.(CLBS)$ 内部交易: 2017-02-03,Director,Wei Eric ,卖出,1525普通股, $4.76
$Caladrius Biosciences, Inc.(CLBS)$ 内部交易: 2017-02-02,Director,Wei Eric ,卖出,6400普通股, $4.56
$Caladrius Biosciences, Inc.(CLBS)$ CORRESP [Cover] - Correspondence Filed: 2016-12-16 AccNo: 0001144204-16-140063 Size: 9 KB 网页链接
$Caladrius Biosciences, Inc.(CLBS)$ UPLOAD [Cover] - SEC-generated letter Filed: 2016-11-30 AccNo: 0000000000-16-102866 Size: 36 KB 网页链接
$Caladrius Biosciences, Inc.(CLBS)$ 8-K - Current report Filed: 2016-12-30 AccNo: 0000320017-16-000171 Size: 22 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers http:...